Skip to main content

Advertisement

Table 3 Pyridoxine effect on the lipid composition (mol %) and fluorescence anisotropy (rs) of DPH in erythrocyte membranes

From: Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine

   Days of treatment  
  Basal 1 30 60 Basal 2
Phospholipids 65.8 ± 0.9a 57.3 ± 0.5b 57.8 ± 0.8b 58.0 ± 1.3b
Cholesterol 33.2 ± 0.9a 38.2 ± 0.6b 37.5 ± 0.8b 39.1 ± 1.3b
Triglyceride 0.4 ± 0.03a 2.0 ± 0.1b 2.1 ± 0.1b 1.0 ± 0.2c
Free fatty acids 0.6 ± 0.01a 2.5 ± 0.1b 2.6 ± 0.1b 1.9 ± 0.2c
Cholesterol/phospholipids 0.50 0.67 0.65 0.67
rs 0.235 ± 0.001a 0.249 ± 0.002b 0.249 ± 0.002b 0.253 ± 0.002a
  1. Data are the mean ± SEM. Values not bearing the same superscript letter are significantly different at P < 0.05.